BELITE BIO, INC (BLTE) Form 6-K — Oct 19, 2026
Belite Bio (NASDAQ: BLTE) announced on October 19, 2026 that Nasdaq approved transferring its listing from the Nasdaq Capital Market to the Nasdaq Global Select Market, the highest of Nasdaq's three tiers, with trading beginning the same day under the existing ticker BLTE. The uplisting reflects Belite Bio's compliance with the Global Select Market's more stringent financial and liquidity standards and is expected to enhance visibility among institutional investors, improve liquidity, and broaden market recognition.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.